Patents by Inventor Umit Cifter

Umit Cifter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140377350
    Abstract: Bilayer Tablet Formulations of Flurbiprofen And Glucosamin The present invention relates to a bilayer tablet formulation of flurbiprofen and glucosamine. Particularly, the present invention relates to a bilayer tablet formulation having a controlled release flurbiprofen and immediate release glucosamine; furthermore relates to their process and use.
    Type: Application
    Filed: January 28, 2013
    Publication date: December 25, 2014
    Inventors: Umit Cifter, Ali Turkyilmaz, Onur Mutlu
  • Publication number: 20140377343
    Abstract: The present invention relates to a pharmaceutical formulation, characterized by comprising flurbiprofen or a pharmaceutically acceptable salt of flurbiprofen, diacerein or a pharmaceutically acceptable salt of diacerein, as well as at least one or a properly-proportioned mixture of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer or polyvinyl alcohol-polyethylene glycol copolymer.
    Type: Application
    Filed: December 20, 2012
    Publication date: December 25, 2014
    Inventors: Umit Cifter, Ali Turkyilmaz, Nur Pahlivan Akalin, Sibel Zenginer
  • Publication number: 20140371318
    Abstract: The present invention relates to an orally-disintegrating pharmaceutical formulation, which is characterized by comprising flurbiprofen and polyvinylcaprolactam-polyvinyl acetate-polyethylene glycol graft copolymer.
    Type: Application
    Filed: December 20, 2012
    Publication date: December 18, 2014
    Inventors: Umit Cifter, Ali Turkyilmaz, Nur Pehlivan Akalin, Ramazan Onder, Esra Sucuoglu
  • Publication number: 20140363508
    Abstract: The present invention relates to pharmaceutical formulations of flurbiprofen or a pharmaceutically acceptable salt thereof and glucosamine or salts thereof. Particularly, the present invention relates to a stable formulation of this combination having desired levels of dissolution rate and solubility which comprises at least one polymer having a low glass transition temperature.
    Type: Application
    Filed: December 20, 2012
    Publication date: December 11, 2014
    Inventors: Umit Cifter, Ali Turkyilmaz, Onur Mutlu
  • Patent number: 8906949
    Abstract: Silicon dioxide free orally disintegrating tablet formulations of zolmitriptan or a pharmaceutically acceptable salt thereof having magnesium carbonate heavy and sodium stearyl fumarate with one or more pharmaceutically acceptable excipients and a process for preparing such a formulation and its use in the treatment of migraines.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: December 9, 2014
    Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Gulay Yelken
  • Publication number: 20140336148
    Abstract: The present invention relates to novel pharmaceutical combinations with synergistic action of diacerein or a pharmaceutically acceptable salt of diacerein and non-steroidal inflammatory drugs, having analgesic, anti-inflammatory, antipyretic, and osteoarthritis-treating activities.
    Type: Application
    Filed: December 25, 2012
    Publication date: November 13, 2014
    Inventors: Umit Cifter, Ali Turkyilmaz, Nur Pahlivan Akalin, Sibel Zenginer, Onur Mutlu
  • Publication number: 20140322338
    Abstract: This invention relates to a pharmaceutical formulation, characterized by comprising flurbiprofen and polyvinylcaprolactam-polyvinyl acetate-polyethylene glycol graft copolymer.
    Type: Application
    Filed: December 20, 2012
    Publication date: October 30, 2014
    Applicant: Sanovel IIac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Nur Pahlivan Akalin, Ilayda Balci
  • Publication number: 20140315843
    Abstract: The present invention relates to a topical pharmaceutical composition of thiocolchicoside and methylsulfonylmethane comprising at least one penetration enhancer and one or more gelling agent. Furthermore, the invention relates to process for preparing the said topical pharmaceutical composition and its use for the treatment of pain and inflammatory symptoms associated with muscle-skeletal system and osteoarthritis.
    Type: Application
    Filed: December 14, 2012
    Publication date: October 23, 2014
    Inventors: Umit Cifter, Ali Turkyilmaz, Nur Pehlivan Akalin, Ramazan Onder
  • Publication number: 20140308348
    Abstract: This invention is a novel pharmaceutical composition comprising flurbiprofen or a pharmaceutically acceptable salt thereof in combination with an ?-2 adrenergic receptor agonist or a gamma-aminobutiric acid receptor agonist with anti-inflammatory, analgesic and myorelaxant activity.
    Type: Application
    Filed: May 20, 2014
    Publication date: October 16, 2014
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp
  • Publication number: 20140302150
    Abstract: The present invention relates to a pharmaceutical formulation, characterized by comprising a DPP-IV inhibitor and polyvinylcaprolactam-polyvinyl acetate-polyethylene glycol graft copolymer.
    Type: Application
    Filed: September 5, 2012
    Publication date: October 9, 2014
    Inventors: Umit Cifter, Ali Turkyilmaz, Gulay Yelken, Mehtap Saydam
  • Patent number: 8778391
    Abstract: This invention is a novel pharmaceutical composition comprising flurbiprofen or a pharmaceutically acceptable salt thereof in combination with an ?-2 adrenergic receptor agonist or a gamma-aminobutiric acid receptor agonist with anti-inflammatory, analgesic and myorelaxant activity.
    Type: Grant
    Filed: May 8, 2008
    Date of Patent: July 15, 2014
    Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp
  • Patent number: 8758818
    Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: June 24, 2014
    Assignee: Sanovel Ilac Sanayi ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Patent number: 8753682
    Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: June 17, 2014
    Assignee: Sanovel Ilac Sanayi ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Patent number: 8741345
    Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: June 3, 2014
    Assignee: Sanovel ILAC Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Patent number: 8691778
    Abstract: A topical pharmaceutical gel includes flurbiprofen or a pharmaceutically acceptable salt of flurbiprofen, thiocolchicoside or a pharmaceutically acceptable salt of thiocolchicoside, and menthol. Pharmaceutical combinations of flurbiprofen, thiocolchicoside, and menthol in the form of topical gels with anti-inflammatory, analgesic, and myorelaxant activities are described.
    Type: Grant
    Filed: September 20, 2010
    Date of Patent: April 8, 2014
    Assignee: Sanovel Ilac Sanayi ve Ticaret Anonim Sirketi
    Inventors: Fatih Cakir, Ali Turkyilmaz, Umit Cifter
  • Publication number: 20140030328
    Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: September 23, 2013
    Publication date: January 30, 2014
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Publication number: 20140023709
    Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: September 23, 2013
    Publication date: January 23, 2014
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Patent number: 8563034
    Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: October 22, 2013
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Patent number: 8563035
    Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: October 22, 2013
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Publication number: 20110305757
    Abstract: A pharmaceutical composition including a compound of Formula I (Compound I) or pharmaceutically acceptable salts thereof and one or more diuretics as effective components, wherein said one or more diuretics are selected from thiazide derivatives. Methods for preparing the pharmaceutical compound including Compound I and thiazide derivatives and its use for preventing or treating hypertension in mammals, particularly in humans.
    Type: Application
    Filed: June 13, 2011
    Publication date: December 15, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Onur Mutlu, Gaye Ramazanoglu